Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) shares hit a new 52-week low on Friday . The stock traded as low as $0.6017 and last traded at $0.6017, with a volume of 250 shares trading hands. The stock had previously closed at $0.6331.
Sino Biopharmaceutical Stock Performance
The company has a 50 day moving average of $0.70 and a two-hundred day moving average of $0.79.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Read More
- Five stocks we like better than Sino Biopharmaceutical
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
